The WACC of Heron Therapeutics Inc (HRTX) is 7.7%.
Range | Selected | |
Cost of equity | 7.30% - 11.10% | 9.20% |
Tax rate | 26.20% - 27.00% | 26.60% |
Cost of debt | 5.30% - 7.00% | 6.15% |
WACC | 6.2% - 9.2% | 7.7% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.74 | 1.12 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 7.30% | 11.10% |
Tax rate | 26.20% | 27.00% |
Debt/Equity ratio | 0.46 | 0.46 |
Cost of debt | 5.30% | 7.00% |
After-tax WACC | 6.2% | 9.2% |
Selected WACC | 7.7% | |